Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 204-211

  Lin, Yu Sheng ^a,b   Tung, Tao Hsin ^c,d   Wang, Jui ^e   Chen, Yu Fen ^f,g,h   Chen, Tien Hsing ^a   Lin, Ming Sheng ^a   Chi, Ching Chi ^a,b   Chen, Mien Cheng ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f DEPARTMENT OF HEALTH   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

^h Kang Ning Junior College of Medical Care and Management   (Taiwan)

Author keywords

Atrial fibrillation; Cardiovascular death; Heart failure; Peripheral arterial disease; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TAIWAN; CARDIOVASCULAR DISEASES; COMPLICATION; JAPAN; MIDDLE AGED; MORTALITY; STATISTICS AND NUMERICAL DATA; STROKE; YOUNG ADULT;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; JAPAN; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84952642580     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.10.091     Document Type: Article

References (39)

1. B.P. Krijthe, A. Kunst, E.J. Benjamin, G.Y. Lip, O.H. Franco, A. Hofman, and et al. Projections on the number of individuals with atrial fibrillation in the European union, from 2000 to 2060 Eur. Heart J. 34 2013 2746 2751
2. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am. J. Cardiol. 82 1998 2N 9N
3. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study JAMA 271 1994 840 844
4. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, and et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology Europace 12 2010 1360 1420
5. C.T. Ruff, D.L. Bhatt, P.G. Steg, B.J. Gersh, M.J. Alberts, E.B. Hoffman, and et al. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the reach registry Int. J. Cardiol. 170 2014 413 418
6. E. Selvin, and T.P. Erlinger Prevalence of and risk factors for peripheral arterial disease in the united states: results from the national health and nutrition examination survey, 1999-2000 Circulation 110 2004 738 743
7. J.J. Manzano, D.A. De Silva, J.L. Pascual, H.M. Chang, M.C. Wong, and C.P. Chen Associations of ankle-brachial index (abi) with cerebral arterial disease and vascular events following ischemic stroke Atherosclerosis 223 2012 219 222
8. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, J.W. Olin, and et al. Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
9. M.V. Perez, P.J. Wang, J.C. Larson, E.Z. Soliman, M. Limacher, B. Rodriguez, and et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the women's health initiative observational study Heart 99 2013 1173 1178
10. F. Violi, G. Davi, W. Hiatt, G.Y. Lip, G.R. Corazza, F. Perticone, and et al. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy J. Am. Coll. Cardiol. 62 2013 2255 2256
11. F. Violi, G.Y. Lip, and S. Basili Peripheral artery disease and atrial fibrillation: a potentially dangerous combination Int. Emerg. Med. 7 2012 213 218
12. J.B. Olesen, G.Y. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, J. Lindhardsen, and et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
13. J.B. Olesen, G.Y. Lip, D.A. Lane, L. Kober, M.L. Hansen, D. Karasoy, and et al. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study Am. J. Med. 125 826 2012 e13 e23
14. W.T. O'Neal, J.T. Efird, S. Nazarian, A. Alonso, S.R. Heckbert, and E.Z. Soliman Peripheral arterial disease and risk of atrial fibrillation and stroke: the multi-ethnic study of atherosclerosis J. Am. Heart Assoc. 3 2014 e001270
15. C.Y. Wu, Y.J. Chen, H.J. Ho, Y.C. Hsu, K.N. Kuo, M.S. Wu, and et al. Association between nucleoside analogues and risk of hepatitis b virus-related hepatocellular carcinoma recurrence following liver resection JAMA 308 2012 1906 1914
16. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol. Drug Saf. 2011;20:236-42.
17. C.S. Wu, M.S. Lai, S.S.F. Gau, S.C. Wang, and H.J. Tsai Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan PLoS ONE 9 2014 e112257
18. S. Chotchaisuwatana, A. Jedsadayanmata, N. Chaiyakunapruk, and K. Jampachaisri Validation of electronic medical database in patients with atrial fibrillation in community hospitals J. Med. Assoc. Thail. 94 2011 686 692
19. J. Fan, A.M. Arruda-Olson, C.L. Leibson, C. Smith, G. Liu, K.R. Bailey, and et al. Billing code algorithms to identify cases of peripheral artery disease from administrative data J. Am. Med. Inform. Assoc. 20 2013 e349 e354
20. Karen A. Hicks, H. M. James Hung, Kenneth W. Mahaffey, Roxana Mehran, Steven E. Nissen, Norman L. Stockbridge, et al.; on behalf of the Standardized Data Collection for Cardiovascular Trials Initiative Standardized definitions for end point events in cardiovascular trials. Available at: http://www/ cdisc.org/stuff/contentmgr/files/0/2356ae38ac190ab8ca4ae0b222392b37 /misc/cdisc. (Accessed Nov16), 2010
21. M.J. Knol, I. van der Tweel, D.E. Grobbee, M.E. Numans, and M.I. Geerlings Estimating interaction on an additive scale between continuous determinants in a logistic regression model Int. J. Epidemiol. 36 2007 1111 1118
22. L.H. Rasmussen, T.B. Larsen, K.M. Due, A. Tjønneland, K. Overvad, and G.Y. Lip Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study J. Thromb. Haemost. 9 2011 1301 1307
23. M. Disertori, R. Latini, S. Barlera, M.G. Franzosi, L. Staszewsky, A.P. Maggioni, and et al. Valsartan for prevention of recurrent atrial fibrillation N. Engl. J. Med. 360 2009 1606 1617
24. T.A. Winkel, S.E. Hoeks, O. Schouten, U. Zeymer, T. Limbourg, I. Baumgartner, and et al. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the reduction of atherothrombosis for continued health (reach) registry Eur. J. Vasc. Endovasc. Surg. 40 2010 9 16
25. J.S. Hiramoto, R. Katz, S. Weisman, and M. Conte Gender-specific risk factors for peripheral artery disease in a voluntary screening population J. Am. Heart Assoc. 3 2014 e000651
26. S.C. Marott, S.F. Nielsen, M. Benn, and B.G. Nordestgaard Antihypertensive treatment and risk of atrial fibrillation: a nationwide study Eur. Heart J. 35 2014 1205 1214
27. X. Zhou, J.L. Du, J. Yuan, and Y.Q. Chen Statin therapy is beneficial for the prevention of atrial fibrillation in patients with coronary artery disease: a meta-analysis Eur. J. Pharmacol. 707 2013 104 111
28. F. Vancheri Trends in coronary heart disease mortality and statin utilization in two European areas with different population risk levels: Stockholm and Sicily Int. Cardiovasc. Forum J. 1 2014 140 146
29. S. Adamsson Eryd, G. Ostling, M. Rosvall, M. Persson, J.G. Smith, O. Melander, and et al. Carotid intima-media thickness is associated with incidence of hospitalized atrial fibrillation Atherosclerosis 233 2014 673 678
30. K. Willeit, R. Pechlaner, G. Egger, S. Weger, M. Oberhollenzer, J. Willeit, and et al. Carotid atherosclerosis and incident atrial fibrillation Arterioscler. Thromb. Vasc. Biol. 33 2013 2660 2665
31. M. Proietti, C. Calvieri, L. Malatino, S. Signorelli, G.R. Corazza, F. Perticone, and et al. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type Atherosclerosis 238 2015 350 355
32. A. Banerjee, F.G. Fowkes, and P.M. Rothwell Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention Stroke 41 2010 2102 2107
33. C. Diehm, J.R. Allenberg, D. Pittrow, M. Mahn, G. Tepohl, R.L. Haberl, and et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease Circulation 120 2009 2053 2061
34. R.G. Aleong, W.H. Sauer, G. Davis, and M.R. Bristow New-onset atrial fibrillation predicts heart failure progression Am. J. Med. 127 2014 963 971
35. W.S. Aronow, M.I. Ahmed, O.J. Ekundayo, R.M. Allman, and A. Ahmed A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults Am. J. Cardiol. 103 2009 130 135
36. W.S. Jones, R. Clare, S.J. Ellis, J.S. Mills, D.L. Fischman, W.E. Kraus, and et al. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION) Am. J. Cardiol. 108 2011 380 384
37. E. Birman-Deych, A.D. Waterman, Y. Yan, D.S. Nilasena, M.J. Radford, and B.F. Gage Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors Med. Care 43 2005 480 485
38. K.K. Patton, S.R. Heckbert, A. Alonso, H. Bahrami, J.A. Lima, G. Burke, and et al. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the multi-ethnic study of atherosclerosis: the effects of age, sex and ethnicity Heart 99 2013 1832 1836
39. A. Micari, G. Vadalà, M. Corbo, G. D'Alessandro, F. Castriota, and A. Cremonesi An analysis of the economic impact of drug-coated balloon use for the treatment of peripheral artery disease Int. Cardiovasc. Forum J. 3 2015 20 25